Access to Information Requests Completed - October 2011

This content was archived on June 24, 2013.

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

Completed Requests

For the month of October 2011

Request #	Summary of Requests	Status of Completed Request	Number of Pages Disclosed
A-2008-00974	All documents about health claims for foods containing probiotics.  (August 2008 and January 2009).	Disclosed in part	730
A-2009-00993	Information regarding the products Apri 21 and Apri 28, DINs 02317192 and 02317206 by Barr Laboratories Inc.	Disclosed in part	792
A-2009-01277	Please provide all correspondence between Dr. Richard Larouche and Health Canada that took place between January 1, 2005 and January 1, 2007 during which Dr. Larouche was Director of Medical Affairs for Anapharm.	Disclosed in part	164
A-2009-01289	All information regarding the Standing Offer Solicitation # 1000101211.	Disclosed in part	285
A-2010-00154	All documents for the medical device Durom Acetabular Cup (also known as Durom Hip Resurfacing System Acetabular Component) manufactured by Zimmer GMBH. (Jan 1, 2004 to Apr 13, 2010).	Disclosed in part	245
A-2010-00451	Information regarding the product Kids Probiotic Supplement, NPN 80011336 by Wakunaga of America.	Disclosed in part	25
A-2010-00515	Information regarding the product DROPS, NPN 80001791 by Ddrops Company.	Disclosed in part	85
A-2010-00589	Information regarding the product HP-PAC, DIN 02238525.	Disclosed in part	342
A-2010-00868	Information regarding the product Hyzaar, by MERCK FROSST CANADA.	Disclosed in part	218
A-2010-00873	Information regarding the product Spiriva, DIN 02246793 by BOEHRINGER INGELHEIM (CANADA) LTD./LTEE.	Disclosed in part	1,759
A-2010-00940	All documents, relating to 'plain packaging' proposals for tobacco products, from non-government organizations and from Tobacco Product Manufacturers. (Jan 1, 1996 to Dec 1, 2010).	Disclosed in part	1,607
A-2010-00941	All documents, relating to 'plain packaging' proposals for tobacco products, prepared for the Minister in preparation for testimony before Parliamentary Committees on the Tobacco Act, and other government departments and the activities of other jurisdictions. (Jan 1, 1996 to Dec 1, 2010).	Disclosed in part	1,767
A-2010-00943	All documents, relating to 'plain packaging' proposals for tobacco products, prepared for international treaty negotiations. (Jan 1, 1996 to Dec 1, 2010).	Disclosed in part	2,027
A-2010-00969	All the basis, scientific, support, rationale for this decision pertaining to Simian Foamy Virus (SFV) testing/retesting.	Disclosed in part	1,435
A-2010-00988	All documents to substantiate the visual statement and voice-over stating 'Did you know that sugar-sweetened drinks are linked to childhood obesity?', as conveyed in the television advertisement that began airing around November 22, 2010. (Dec 16, 2009 to Jan 18, 2011).	Disclosed in part	403
A-2010-01048	All documents related to a June 10, 2010 letter from British Columbia Health Minister to Minister Aglukkaq on tobacco.	Disclosed in part	31
A-2010-01120	All documents related to policy development for the proposal to revoke the 0.1 parts per million (ppm) general Regulation in the Food and Drug Regulation B.15.002(1). (1987 to Jan 21, 2011).	Disclosed in part	3,593
A-2010-01242	All correspondence pertaining to the marketing or advertising regulation or oversight of Neurontin (gabapentin), a drug originally manufactured and sold in Canada by Warner-Lambert, later acquired by Pfizer in 2000. (1994 to Feb 8, 2011).	Disclosed in part	188
A-2010-01411	All documents regarding AquAdvantage salmon by AquaBounty Technologies. (Sep 1, 2010 to Feb 25, 2011).	Disclosed in part	27
A-2010-01419	All documents that allowed the registration of the product Risperdal M by Janssen Inc.	Disclosed in part	143
A-2010-01561	Information regarding the product Velbe 1 mg/mL, DIN 00015431 by Eli Lilly Canada Inc.	Disclosed in part	7
A-2010-01580	All emails to/from Dr. Robin Marles about energy drinks from January 1, 2010 to August 31, 2010.	Disclosed in part	62
A-2010-01583	Information regarding the product Lutein 6 mg, NPN 80002113 by Swiss Herbal Remedies Ltd /TheraPro.	Disclosed in part	44
A-2011-00033	Copies of the supporting review which formed the basis of the changes requested in March 1, 2011 letter from Health Canada entitled REQUESTED TO UPDATE THE PRODUCT MONOGRAPH FOR GADOLIDIUM-BASED CONTRAST AGENTS (Magnevist).	Disclosed in part	824
A-2011-00044	Information regarding the product PURG-ODAN, DIN 02317966 by ODAN LABORATORIES LTD.	Disclosed in part	67
A-2011-00055	Information regarding the product Docetaxel for injection by Hospira Healthcare Corporation.	Disclosed in part	266
A-2011-00067	Information regarding the product PMS-FLUCONAZOLE, DIN 02246620 by Pharmascience Inc.	Disclosed in part	56
A-2011-00070	Information regarding the product ASA DAILY LOW DOSE, DIN 02243101 by Pharmascience Inc.	Disclosed in part	189
A-2011-00118	Information regarding the product Sunscreen lotion écran solaire 15, DIN 02230859.	Disclosed in part	26
A-2011-00153	Information regarding the product Omega 3, NPN 80015284 by JAMIESON.	Disclosed in part	23
A-2011-00172	Information regarding the product Requip (also known as Ropinirole).	Disclosed in part	517
A-2011-00212	AERs for the product Humira. Report numbers: 000348690, 000349875, 000349877, 000350027, 000351426 and 000351888.	Disclosed in part	13
A-2011-00305	Documents authored by or on behalf of the government of Canada between 1 January 1998 and June 6, 2011 containing or referring to the reasons why plain packaging was not or has not been introduced in Canada.	Disclosed in part	594
A-2011-00306	Documents addressing or considering whether plain packaging is consistent with the trade and investment treaties to which Canada is a party, created between 1 January 1998 and June 6, 2011.	Disclosed in part	445
A-2011-00312	The scientific, technical, compositional, safety and efficacy data which supports and continues to support the approval of the entire scope of usage of Oat hull-ground bleached Vitacel HF301CA.	Disclosed in part	98
A-2011-00316	AER. Report number: 000307744.	Disclosed in part	6
A-2011-00325	All documents in MECS for the following files: 10-102258-801, 10-107306-417, 10-101369-34, 10-108186-993 and 10-000872-523.	Disclosed in part	92
A-2011-00327	All documents in MECS for the following files: 10-112118-700, 10-10113246-706, 10-111130-177, 10-104497-204, 10-112891-827, 10-112643-463, 10-113226-214 and 10-117264-534.	Disclosed in part	403
A-2011-00330	All documents in MECS for the following files: 10-123074-226, 10-123021-307, 10-120951-948, 10-124539-953, 10-125563-341, 10-101512-184 and 10-108578-431.	Disclosed in part	176
A-2011-00341	Information regarding the product MEGACE OS, DIN 02168979.	Disclosed in part	52
A-2011-00359	Information regarding the product VICTOZA, DINs 02351056 and 02351064 by NOVONORDISK CANADA INC.	Disclosed in part	290
A-2011-00383	A copy of agendas, minutes and supporting documents for Health Canada's Food Directorate/Natural Health Product Directorate Working Group. (Jul 1 2010 to Dec 30 2010).	No records exist	0
A-2011-00411	All documents in MECS for the following files: 10-008691-426	All disclosed	6
A-2011-00431	All documents prepared for the Minister of Health and the Chief Public Health Officer relating to the Ocean Lady, which arrived in British Columbia October 17, 2009. (Aug 1, 2009 to Aug 1, 2010).	All disclosed	3
A-2011-00437	AERs for the product Kaletra. Report numbers: 000355365. 000356691 and 000358203.	Disclosed in part	18
A-2011-00471	Documentation which indicates the names, phone numbers, and email addresses of Health Canada staff that are currently authorised to use the PWGSC temporary help services ordering and purchasing system.	All disclosed	30
A-2011-00496	Correspondence between Janssen-Ortho Inc. and Health Canada regarding Novo-methylphenidate ER-C.	Disclosed in part	1
A-2011-00497	AERs for the product Cipralex. Report numbers: 000359583, 000362765, 000364069, 000364499 and 000364738.	Disclosed in part	29
A-2011-00503	All documents concerning the 2009 update of Safety Code 6 (Limits of Human Exposure to Radiofrequency Electromagnetic Energy in the Frequency Range from 3 kHz to 300 GHz).	Disclosed in part	293
A-2011-00506	AERs for the product Isentress. Report numbers: 000326165, 000316012 and 000326745.	Disclosed in part	27
A-2011-00512	Information regarding the product B-12 2500 Mcg, NPN 80020100 by Vita Heath Products Inc.	Disclosed in part	355
A-2011-00556	Documents' regarding Michael Lebelle's decision mephedrone is a controlled substance on Oct 16, 2009.	Disclosed in part	68
A-2011-00565	All correspondence with the Canada Border Services Agency regarding the appeal by Euro Dried & Design Elements to import dried Certified Low Morphine dietary grade poppies. (Jan 15, 2011 to Aug 5, 2011).	All disclosed	22
A-2011-00597	All documents relating to the dispersal of funds under the budget line Capital Expenditures, for the 2009-2010 fiscal year.	All disclosed	4
A-2011-00598	All documents relating to the dispersal of funds under the budget line Capital Expenditures, for the 2010-2011 fiscal year.	All disclosed	4
A-2011-00600	All documents relating to the dispersal of funds under the budget line Grants and Contributions, for the 2009-2010 fiscal year.	All disclosed	4
A-2011-00601	All documents relating to the dispersal of funds under the budget line Grants and Contributions, for the 2010-2011 fiscal year.	All disclosed	4
A-2011-00605	Information regarding the total cost of all product promotions other than accessories reported by tobacco manufacturers and importers per section 24 of the Tobacco Reporting Regulations. (Jan 1, 2010 to Jun 30, 2011).	No records exist	0
A-2011-00607	Information regarding the total cost of all accessory promotions reported by tobacco manufacturers and importers per section 23 of the Tobacco Reporting Regulations. (Jan 1, 2010 to Jun 30, 2011).	No records exist	0
A-2011-00608	Information regarding the total cost of all payments to services to use consumer tobacco product related-brand elements reported by tobacco manufacturers and importers under section 21 of the Tobacco Reporting Regulations. (Jan 1, 2010 to Jun 30, 2011).	No records exist	0
A-2011-00613	Information regarding the product High Potency Coq10, NPN 80023959.	Disclosed in part	208
A-2011-00629	AERs for the products PEG-INTRON and PEGETRON. Report numbers: 000306467 and 000300391.	Disclosed in part	7
A-2011-00662	Pest Management Regulatory Agency (PMRA) Pesticide Sales Registry.	All disclosed	1,800
A-2011-00665	All documents pertaining to requests for exemptions from the Controlled Drugs and Substance Act for the importation or exportation of controlled opioid narcotics, analgesics, or anaesthetics for humanitarian missions in Haiti following the January 2010 earthquake.	Disclosed in part	19
A-2011-00671	Product Monograph for APO-Midazolam Injectable, DINs 02243253 and 02243254 by Apotex Inc.	All disclosed	42
A-2011-00672	Product Monograph for Midazolam Injectable, DINs 02240285 and 02240286 by Sandoz Canada Inc.	All disclosed	39
A-2011-00675	Documents regarding the classified radiofrequencies as a group 2b carcinogen meeting of the World Health Organization / International Agency for Research on Cancer, in Lyon France.	Disclosed in part	132
A-2011-00689	All documents of the Monthly Discretionary Fortification Meeting. (Jan 1, 2011 to Sep 8, 2011).	Disclosed in part	13
A-2011-00699	AER for the product Multaq. Report number: 000372692.	Disclosed in part	1
A-2011-00700	AERs for the product Daxas. Report numbers: 000367809, 000368197, 000368320 and 000373219.	Disclosed in part	5
A-2011-00701	AERs for the product Omnaris. Report numbers: 000369335 and 000369773.	Disclosed in part	2
A-2011-00702	AERs for the product Pantoloc. Report numbers: 000368469 and 000371524.	Disclosed in part	2
A-2011-00703	AERs for the product Tecta. Report numbers: 000368969 and 000372134.	Disclosed in part	2
A-2011-00707	Previously released request A-2008-00301: Information regarding chrysotile asbestos.	All disclosed	154
A-2011-00709	AERs for the product Aleve. Report numbers: 000367239, 000367948 and 000369931.	Disclosed in part	4
A-2011-00711	AERs for the product CanesOral. Report numbers: 000365532, 000365546 and 000371027.	Disclosed in part	5
A-2011-00726	Casual and Term contracts in the National Capital Region, that are ending within the months October, November, December 2011 and January, February, March 2012.	All disclosed	4
A-2011-00728	Contracts, Request for Proposals, Proposals and Final Reports submitted by supplied to Positive Regulatory Outcomes Consulting.	Disclosed in part	39
A-2011-00747	List of all Aboriginal health facilities which were audited / assessed as part of the Integrated Facility Audit campaign.	All disclosed	10
A-2011-00751	Information on all Transfer Payments for the 2010- 2011 reporting period awarded by Health Canada.	All disclosed	21
A-2011-00753	Statistically significant findings that linked the consumption of dairy products to risk of disease as per the Eating well with Canada's Food Guide (2007): Development of the Food Intake Pattern in April 2007, in which researchers assessed the relationship between various foods and risk of chronic disease.	No records exist	0
A-2011-00755	All documents from the playpens and cribs and cradles committees. February 25, 2011 and September 19, 2011.	No records exist	0
A-2011-00757	All local purchase orders processed by this institution in the National Capital Region for the procurement of Temporary Help Services during the period of September 2011.	No records exist	0
A-2011-00758	Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during September 2011.	All disclosed	4
A-2011-00759	All call-ups and amendments issued under the terms of the TBIPS Standing Offer (EN578-055605) in the National Capital Region during the month of September 2011.	No records exist	0
A-2011-00760	All information regarding the use of chimpanzee data from United States laboratories in Canadian research in the last 5 years.	No records exist	0
A-2011-00764	List of all Question Period notes created for the minister of Health Canada. (Aug 1, 2011 to Sep 27, 2011).	All disclosed	2
A-2011-00765	AER. Report number: 000326399.	Disclosed in part	1
A-2011-00784	AERs. Report numbers: 000371795, 000371797, 000371794, 000373166, 000373167, 000373519 and 000372664.	Disclosed in part	24
A-2011-00791	Previously released request A-2007-00875: Information regarding authorized medical cannabis users.	All disclosed	1
A-2011-00793	A listing of the Access to Information requests submitted to Health Canada. (Sep 1, 2011 to Sep 30, 2011).	Disclosed in part	7
A-2011-00794	Product Monograph for INCIVEK (telaprevir) by VERTEX PHARMACEUTICALS (CANADA) INC.	No records exist	0
A-2011-00805	All documents between senior officials / management of pharmaceutical companies and their lobbyists concerning the decision not to produce life-saving cancer drugs in order to continue profiting from sales of other less-effective, although more profitable drugs.	No records exist	0